Le Lézard
Classified in: Health, Covid-19 virus
Subjects: NPT, POL, AVO

Savings Behind President Trump's Executive Order Lowering Prescription Drug Prices Through Personal Importation

WASHINGTON, July 28, 2020 /PRNewswire/ -- The Campaign for Personal Prescription Importation (CPPI) released the below statement following President Donald J. Trump's signing of an executive order giving Americans access personally import safe and access affordable medicines from abroad.

"Americans' need for affordable prescription drugs has never been greater then it is right now amid the Coronavirus pandemic. President Trump's executive order rightly opens the door for Americans' to access safe prescription drugs through accredited Canadian pharmacies. These pharmacies provide medicines at a fraction of the price that consumers pay for the same medicines in the U.S.," said Jack Pfeiffer, executive director of the Campaign for Personal Prescription Importation.

"While federal legislation has been evasive, for years millions of Americans have turned to personal prescription importation from licensed Canadian pharmacies as prices in the U.S. soared."

Full Text of Executive Order on Increasing Drug Importation to Lower Prices for American Patients

Savings Behind Personal Prescription Importation from Online Canadian Pharmacies

A CPPI Personal Prescription Importation Survey released July 13, 2020, highlights the incredible savings that Americans can access through personal prescription importation:

Taking Advantage of Personal Prescription Importation Savings

Over 2.4 million Americans have been importing prescription drugs from foreign countries for years. The new Executive Order, further eases restrictions and clarifies the U.S. government's support for the practice of personal prescription importation. Americans do not need to wait to take advantage of the incredible savings, they can take these easy steps now:

About the Campaign for Personal Prescription Importation
The Campaign for Personal Prescription Importation (CPPI) is a national nonprofit patient advocacy organization that fights for Americans' access to safe, affordable prescription medications from Canada for personal use. Tens of millions of Americans ? especially the elderly and others on fixed incomes ? struggle to pay the extremely high price of prescription medications in the U.S. We are here to be their voice.

Hundreds of thousands of Americans use licensed Canadian pharmacies annually, to purchase their daily prescription medications at an affordable price. We believe that all Americans have a right to affordable medications. It is time to change the current U.S. policy on this issue to provide immediate access to life-saving medications, taken daily for chronic health conditions, at affordable prices.

SOURCE Campaign for Personal Prescription Importation

These press releases may also interest you

at 12:06
In lieu of an in-person update to the media, Dr. Theresa Tam, Canada's Chief Public Health Officer, issued the following statement today: "As the resurgence of COVID-19 activity continues in Canada, we are tracking a range of epidemiological...

at 12:06
Karmanos Cancer Institute is pleased to announce that it will begin using the OncoLens cancer treatment planning software platform to hold tumor boards and multidisciplinary case discussions. Implementing OncoLens will make it easier for providers to...

at 12:00
Harvard Eye Associates, one of the country's leading cataract surgery treatment and research centers, announced a new, state-of-the-art cataract treatment called the Light Adjustable Lens this month. The Light Adjustable Lens is the first and only...

at 12:00
In response to the need of healthcare providers for more educational and training resources on evidence-based medicine, including imaging appropriateness, Cranberry Peak Corp. announced today MD Assist, a new software as a service. While not a...

at 11:54
Atlantis Academy Coral Springs, a comprehensive school that provides academic, behavioral, social, and emotional support to students K-12 with various learning needs, is growing to provide more options for parents who desire a safe, small, flexible...

at 11:50
POXEL SA (Euronext: POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), today announced that it will host...

News published on 28 july 2020 at 11:45 and distributed by: